Clinical trial
Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
NCT00098111 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00098111 |
|---|---|
| Title | Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease |
| Official title | A Double-Blinded, Randomized, Parallel Arm, Dose Ranging Study of IMURAN in Subjects With Active Crohn's Disease Requiring Treatment With Prednisone: A Crohn's Disease Optimal Range Dose of IMURAN Study (ACORDIS) |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug |
| Interventions | azathioprine |
| Enrollment | 31 |
| Start date | Apr 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Dec 6, 2004 |
| Last update posted | Feb 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: